¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø CMI 1Ãþ ¼­¼ºÈ¯ ¿¬±¸È¦

±³À°ÁÖÁ¦ : 2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸

´ã´çÀÚ : °íÇö¹Î
¿¬¶ôó : 02-797-1220

À̸ÞÀÏ : ksgkpt@gmail.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 200,000¿ø  

ºñ°í »çÀüµî·Ï) Á¤È¸¿ø- 80,000¿ø ÁØȸ¿ø- 30,000¿ø ºñȸ¿ø- 150,000¿øÇöÀåµî·Ï) Á¤È¸¿ø- 100,000¿ø ÁØȸ¿ø- 50,000¿ø ºñȸ¿ø- 200,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04-14 09:30~10:00 Registration ()

±âŸ 04-14 10:00~10:05 Welcome Address ÇÏÁ¾¿ø(¼­¿ïÀÇ´ë)

±âŸ 04-14 10:05~10:10 Congratulatory address ´ëÇÑ¿Ü°úÇÐȸȸÀå À±µ¿¼·(¿¬¼¼ÀÇ´ë)

±âŸ 04-14 10:10~11:40 Session I. Deceased Donor Kidney Transplantation in KOREA ¹ÚÀç¹ü / ¾ÈÇüÁØ(¼º±Õ°üÀÇ´ë / °æÈñÀÇ´ë)

±³À°½Ã°£ 04-14 10:10~10:40 Current status of DDKT and Kidney Organ Allocation Policy in KOREA ÀüÈ︸(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 10:40~11:10 Deceased Donor KT Expanded criteria donor °í¿µ¹Î(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 11:10~11:40 Role of Machine perfusion Àå¿ø¹è(Á¦ÁÖÀÇ´ë)

±âŸ 04-14 11:40~13:00 Photo/Lunch ()

±âŸ 04-14 13:00~14:30 Session II. Current immunosuppression in kidney transplantation ¹Ú¼øö / Á¤Ã¶¿õ(°¡Å縯ÀÇ´ë / °í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 13:00~13:30 Induction immunosuppression in KT À̱³¿ø(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-14 13:30~14:00 Optimizing trough level and intrapatient variability of tacrolimus in KT ÇѾƶ÷(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 14:00~14:30 Clinical usefulness of mTOR(mammalian target of rapamycin) inhibitor in KT ¼Û½Âȯ(ÀÌÈ­ÀÇ´ë)

ÈÞ½Ä 04-14 14:30~15:00 Coffee Break ()

±âŸ 04-14 15:00~16:30 Session III. Kidney transplantation in high immunologic risk recipients Çã±ÔÇÏ / ±è¿µÈÆ(¿¬¼¼ÀÇ´ë / ¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 15:00~15:30 Pretransplant immunological risk assessment ¹Ú±Ýº¸·¡(KODA)

±³À°½Ã°£ 04-14 15:30~16:00 Current approach to desensitization and transplant outcomes in ABO/HLA(human leukocyte antigen)-incompatible KT ±ÇÇö¿í(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 16:00~16:30 Challenges and limitations of KT in high immunologic risk recipients ÀÌÁÖÇÑ(¿¬¼¼ÀÇ´ë)

±âŸ 04-14 16:30~17:00 Special Session ÇÏÁ¾¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 16:30~17:00 K-NSQIP(National Surgical Quality Improvement Program in Korea) KT ¹Î»óÀÏ(¼­¿ïÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѱٰñ°Ý¿µ»óÀÇÇÐȸ Á¤±âÇмú´ëȸ 1ÀÏÂ÷ : 2023-04-14
´ÙÀ½±Û ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023³â º¸ÇàºÐ¼® ¿öÅ©¼¥ : 2023-04-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21167 ±¤ÁÖ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦85ȸ ±¤ÁÖ °³¿øÀÇ ¹× Àü°øÀÇ ¿¬¼ö°­Á : 2024-07-19 0 29 2024-07-01
21166 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-07-19 0 33 2024-07-01
21165 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ·áÀÎ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-07-19 0 37 2024-07-01
21164 ÀüºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦299Â÷ ¿ù·ÊÁý´ãȸ : 2024-07-19 0 37 2024-07-01
21163 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-07-18 0 31 2024-07-01
21162 °æ±â ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-°æÀÎ(³²ºÎ) : 2024-07-16 0 32 2024-07-01
21161 ¼­¿ï 2024³â 1Â÷ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç ¿¬¼ö°­Á : 2024-07-14 0 40 2024-07-01
21160 ¼­¿ï 2024 Á¦16ȸ ´ëÇѼºÇü¿Ü°úÇÐȸ ´«¼ºÇü¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2024-07-14 0 30 2024-07-01
21159 ¼­¿ï Á¦11ȸ ´ëÇѺñ°úÇÐȸ ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-14 0 33 2024-07-01
21158 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ 2024³â ⸳62ÁÖ³â±â³ä ½ÉÆ÷Áö¾ö : 2024-07-13 0 29 2024-07-01
21157 ¼­¿ï Á¦46ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2024-07-13 0 30 2024-07-01
21156 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 24³â ´ëµ¿¸Æ ½ÉÆ÷Áö¿ò : 2024-07-13 0 27 2024-07-01
21155 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Á¦18Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2024-07-13 0 18 2024-07-01
21154 ¼­¿ï 2024 ¿¬¼¼ÀÇ´ë Á¤Çü¿Ü°úÇб³½Ç ½ÉÆ÷Áö¿ò : ÃÖÁ¾Çõ ±³¼ö Á¤³â±â³ä : 2024-07-13 0 31 2024-07-01
21153 ¼­¿ï ´ëÇÑ¿Ü»óÁßȯÀÚ¿Ü°úÇÐȸ Á¦50Â÷ Áý´ãȸ (Management of upper & lower GI bleeding) : 2024-07-13 0 31 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷